Protagonist Therapeutics PTGX
NASDAQ PTGX
$145.45 -3.35 (-2.25%)
As of: Sep 4, 2026 · 3:11 PM EDT

Protagonist Therapeutics (PTGX) Notes Payables (2018 - 2023)

Analysis

Protagonist Therapeutics (PTGX) Notes Payables (2018 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.58 Bn 130.73 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.33 Bn 77.33 Bn 3.93 Bn
3 Argenx Se 63.43 Bn 58.24 Bn 1.37 Bn
4 Moderna 57.84 Bn 52.70 Bn 52.00 Mn
5 Revolution Medicines 44.01 Bn 44.01 Bn -
6 BeOne Medicines 39.93 Bn 34.83 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.47 Bn 32.16 Bn 992.69 Mn
8 Royalty Pharma 28.39 Bn 27.56 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Protagonist Therapeutics 9.59 Bn 9.59 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 10,000.00
Mar 31, 2023 22,000.00
Dec 31, 2022 69,000.00
Sep 30, 2022 32,000.00
Jun 30, 2022 80,000.00
Mar 31, 2022 380,000.00
Dec 31, 2021 899,000.00
Sep 30, 2021 1.12 Mn
Jun 30, 2021 11.40 Mn
Mar 31, 2021 6.82 Mn
Dec 31, 2020 2.73 Mn
Sep 30, 2020 2.08 Mn
Jun 30, 2020 1.00 Mn
Mar 31, 2020 1.12 Mn
Dec 31, 2019 1.26 Mn
Sep 30, 2019 1.02 Mn
Jun 30, 2019 810,000.00
Mar 31, 2019 1.21 Mn
Dec 31, 2018 1.06 Mn
Sep 30, 2018 764,000.00